Selected research
Industry Research
Children's Antipyretic Medicine Industry Research Report 2026
Market perspective
The global Children's Antipyretic Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Children's Antipyretic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Children's Antipyretic Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Children's Antipyretic Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Children's Antipyretic Medicine include Zhejiang Kangle, Xinhua Pharmaceutical, Hebei Jiheng, Changshu Huagang, Anhui Fubore, Anhui BBCA Likang, Temad, Strides Shasun and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Children's Antipyretic Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Children's Antipyretic Medicine Market by Company
Zhejiang Kangle
Xinhua Pharmaceutical
Hebei Jiheng
Changshu Huagang
Anhui Fubore
Anhui BBCA Likang
Temad
Strides Shasun
SKPL
Novacyl
Mallinckrodt
IOLCP
Granules India
Granules Biocause
Farmson
Atabay
Anqiu Lu'an
Children's Antipyretic Medicine Segment by Type
Ibuprofen
Acetaminophen
Other
Children's Antipyretic Medicine Segment by Application
Online Sales
Offline Sales
Children's Antipyretic Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children's Antipyretic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children's Antipyretic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children's Antipyretic Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Children's Antipyretic Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Children's Antipyretic Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Children's Antipyretic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Children's Antipyretic Medicine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Children's Antipyretic Medicine Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Children's Antipyretic Medicine Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Children's Antipyretic Medicine Revenue of Manufacturers (2021-2026)
Table 9. Global Children's Antipyretic Medicine Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Children's Antipyretic Medicine Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Children's Antipyretic Medicine Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Children's Antipyretic Medicine, Product Type & Application
Table 14. Global Children's Antipyretic Medicine Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Children's Antipyretic Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Zhejiang Kangle Company Information
Table 19. Zhejiang Kangle Business Overview
Table 20. Zhejiang Kangle Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Zhejiang Kangle Children's Antipyretic Medicine Product Portfolio
Table 22. Zhejiang Kangle Recent Developments
Table 23. Xinhua Pharmaceutical Company Information
Table 24. Xinhua Pharmaceutical Business Overview
Table 25. Xinhua Pharmaceutical Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Xinhua Pharmaceutical Children's Antipyretic Medicine Product Portfolio
Table 27. Xinhua Pharmaceutical Recent Developments
Table 28. Hebei Jiheng Company Information
Table 29. Hebei Jiheng Business Overview
Table 30. Hebei Jiheng Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. Hebei Jiheng Children's Antipyretic Medicine Product Portfolio
Table 32. Hebei Jiheng Recent Developments
Table 33. Changshu Huagang Company Information
Table 34. Changshu Huagang Business Overview
Table 35. Changshu Huagang Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Changshu Huagang Children's Antipyretic Medicine Product Portfolio
Table 37. Changshu Huagang Recent Developments
Table 38. Anhui Fubore Company Information
Table 39. Anhui Fubore Business Overview
Table 40. Anhui Fubore Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Anhui Fubore Children's Antipyretic Medicine Product Portfolio
Table 42. Anhui Fubore Recent Developments
Table 43. Anhui BBCA Likang Company Information
Table 44. Anhui BBCA Likang Business Overview
Table 45. Anhui BBCA Likang Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Anhui BBCA Likang Children's Antipyretic Medicine Product Portfolio
Table 47. Anhui BBCA Likang Recent Developments
Table 48. Temad Company Information
Table 49. Temad Business Overview
Table 50. Temad Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Temad Children's Antipyretic Medicine Product Portfolio
Table 52. Temad Recent Developments
Table 53. Strides Shasun Company Information
Table 54. Strides Shasun Business Overview
Table 55. Strides Shasun Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Strides Shasun Children's Antipyretic Medicine Product Portfolio
Table 57. Strides Shasun Recent Developments
Table 58. SKPL Company Information
Table 59. SKPL Business Overview
Table 60. SKPL Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. SKPL Children's Antipyretic Medicine Product Portfolio
Table 62. SKPL Recent Developments
Table 63. Novacyl Company Information
Table 64. Novacyl Business Overview
Table 65. Novacyl Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Novacyl Children's Antipyretic Medicine Product Portfolio
Table 67. Novacyl Recent Developments
Table 68. Mallinckrodt Company Information
Table 69. Mallinckrodt Business Overview
Table 70. Mallinckrodt Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Mallinckrodt Children's Antipyretic Medicine Product Portfolio
Table 72. Mallinckrodt Recent Developments
Table 73. IOLCP Company Information
Table 74. IOLCP Business Overview
Table 75. IOLCP Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. IOLCP Children's Antipyretic Medicine Product Portfolio
Table 77. IOLCP Recent Developments
Table 78. Granules India Company Information
Table 79. Granules India Business Overview
Table 80. Granules India Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Granules India Children's Antipyretic Medicine Product Portfolio
Table 82. Granules India Recent Developments
Table 83. Granules Biocause Company Information
Table 84. Granules Biocause Business Overview
Table 85. Granules Biocause Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Granules Biocause Children's Antipyretic Medicine Product Portfolio
Table 87. Granules Biocause Recent Developments
Table 88. Farmson Company Information
Table 89. Farmson Business Overview
Table 90. Farmson Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Farmson Children's Antipyretic Medicine Product Portfolio
Table 92. Farmson Recent Developments
Table 93. Atabay Company Information
Table 94. Atabay Business Overview
Table 95. Atabay Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Atabay Children's Antipyretic Medicine Product Portfolio
Table 97. Atabay Recent Developments
Table 98. Anqiu Lu'an Company Information
Table 99. Anqiu Lu'an Business Overview
Table 100. Anqiu Lu'an Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Anqiu Lu'an Children's Antipyretic Medicine Product Portfolio
Table 102. Anqiu Lu'an Recent Developments
Table 103. Global Children's Antipyretic Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 104. Global Children's Antipyretic Medicine Sales by Region (2021-2026) & (K Units)
Table 105. Global Children's Antipyretic Medicine Sales Market Share by Region (2021-2026)
Table 106. Global Children's Antipyretic Medicine Sales by Region (2027-2032) & (K Units)
Table 107. Global Children's Antipyretic Medicine Sales Market Share by Region (2027-2032)
Table 108. Global Children's Antipyretic Medicine Revenue by Region (2021-2026) & (US$ Million)
Table 109. Global Children's Antipyretic Medicine Revenue Market Share by Region (2021-2026)
Table 110. Global Children's Antipyretic Medicine Revenue by Region (2027-2032) & (US$ Million)
Table 111. Global Children's Antipyretic Medicine Revenue Market Share by Region (2027-2032)
Table 112. North America Children's Antipyretic Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. North America Children's Antipyretic Medicine Sales by Country (2021-2026) & (K Units)
Table 114. North America Children's Antipyretic Medicine Sales by Country (2027-2032) & (K Units)
Table 115. North America Children's Antipyretic Medicine Revenue by Country (2021-2026) & (US$ Million)
Table 116. North America Children's Antipyretic Medicine Revenue by Country (2027-2032) & (US$ Million)
Table 117. Europe Children's Antipyretic Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Europe Children's Antipyretic Medicine Sales by Country (2021-2026) & (K Units)
Table 119. Europe Children's Antipyretic Medicine Sales by Country (2027-2032) & (K Units)
Table 120. Europe Children's Antipyretic Medicine Revenue by Country (2021-2026) & (US$ Million)
Table 121. Europe Children's Antipyretic Medicine Revenue by Country (2027-2032) & (US$ Million)
Table 122. Asia Pacific Children's Antipyretic Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Asia Pacific Children's Antipyretic Medicine Sales by Country (2021-2026) & (K Units)
Table 124. Asia Pacific Children's Antipyretic Medicine Sales by Country (2027-2032) & (K Units)
Table 125. Asia Pacific Children's Antipyretic Medicine Revenue by Country (2021-2026) & (US$ Million)
Table 126. Asia Pacific Children's Antipyretic Medicine Revenue by Country (2027-2032) & (US$ Million)
Table 127. South America Children's Antipyretic Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. South America Children's Antipyretic Medicine Sales by Country (2021-2026) & (K Units)
Table 129. South America Children's Antipyretic Medicine Sales by Country (2027-2032) & (K Units)
Table 130. South America Children's Antipyretic Medicine Revenue by Country (2021-2026) & (US$ Million)
Table 131. South America Children's Antipyretic Medicine Revenue by Country (2027-2032) & (US$ Million)
Table 132. Middle East and Africa Children's Antipyretic Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Middle East and Africa Children's Antipyretic Medicine Sales by Country (2021-2026) & (K Units)
Table 134. Middle East and Africa Children's Antipyretic Medicine Sales by Country (2027-2032) & (K Units)
Table 135. Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2021-2026) & (US$ Million)
Table 136. Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2027-2032) & (US$ Million)
Table 137. Global Children's Antipyretic Medicine Sales by Type (2021-2026) & (K Units)
Table 138. Global Children's Antipyretic Medicine Sales by Type (2027-2032) & (K Units)
Table 139. Global Children's Antipyretic Medicine Sales Market Share by Type (2021-2026)
Table 140. Global Children's Antipyretic Medicine Sales Market Share by Type (2027-2032)
Table 141. Global Children's Antipyretic Medicine Revenue by Type (2021-2026) & (US$ Million)
Table 142. Global Children's Antipyretic Medicine Revenue by Type (2027-2032) & (US$ Million)
Table 143. Global Children's Antipyretic Medicine Revenue Market Share by Type (2021-2026)
Table 144. Global Children's Antipyretic Medicine Revenue Market Share by Type (2027-2032)
Table 145. Global Children's Antipyretic Medicine Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Children's Antipyretic Medicine Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Children's Antipyretic Medicine Sales by Application (2021-2026) & (K Units)
Table 148. Global Children's Antipyretic Medicine Sales by Application (2027-2032) & (K Units)
Table 149. Global Children's Antipyretic Medicine Sales Market Share by Application (2021-2026)
Table 150. Global Children's Antipyretic Medicine Sales Market Share by Application (2027-2032)
Table 151. Global Children's Antipyretic Medicine Revenue by Application (2021-2026) & (US$ Million)
Table 152. Global Children's Antipyretic Medicine Revenue by Application (2027-2032) & (US$ Million)
Table 153. Global Children's Antipyretic Medicine Revenue Market Share by Application (2021-2026)
Table 154. Global Children's Antipyretic Medicine Revenue Market Share by Application (2027-2032)
Table 155. Global Children's Antipyretic Medicine Price by Application (2021-2026) & (US$/Unit)
Table 156. Global Children's Antipyretic Medicine Price by Application (2027-2032) & (US$/Unit)
Table 157. Key Raw Materials
Table 158. Raw Materials Key Suppliers
Table 159. Children's Antipyretic Medicine Distributors List
Table 160. Children's Antipyretic Medicine Customers List
Table 161. Children's Antipyretic Medicine Industry Trends
Table 162. Children's Antipyretic Medicine Industry Drivers
Table 163. Children's Antipyretic Medicine Industry Restraints
Table 164. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Children's Antipyretic Medicine Product Image
Figure 5. Global Children's Antipyretic Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Children's Antipyretic Medicine Market Size (2021-2032) & (US$ Million)
Figure 7. Global Children's Antipyretic Medicine Sales (2021-2032) & (K Units)
Figure 8. Global Children's Antipyretic Medicine Average Price (US$/Unit) & (2021-2032)
Figure 9. Ibuprofen Product Image
Figure 10. Acetaminophen Product Image
Figure 11. Other Product Image
Figure 12. Online Sales Product Image
Figure 13. Offline Sales Product Image
Figure 14. Global Children's Antipyretic Medicine Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Children's Antipyretic Medicine Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Children's Antipyretic Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Children's Antipyretic Medicine Sales by Region in 2025
Figure 20. Global Children's Antipyretic Medicine Revenue by Region in 2025
Figure 21. North America Children's Antipyretic Medicine Market Size by Country in 2025
Figure 22. North America Children's Antipyretic Medicine Sales Market Share by Country (2021-2032)
Figure 23. North America Children's Antipyretic Medicine Revenue Market Share by Country (2021-2032)
Figure 24. United States Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Children's Antipyretic Medicine Market Size by Country in 2025
Figure 28. Europe Children's Antipyretic Medicine Sales Market Share by Country (2021-2032)
Figure 29. Europe Children's Antipyretic Medicine Revenue Market Share by Country (2021-2032)
Figure 30. Germany Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Children's Antipyretic Medicine Market Size by Country in 2025
Figure 41. Asia Pacific Children's Antipyretic Medicine Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Children's Antipyretic Medicine Revenue Market Share by Country (2021-2032)
Figure 43. China Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Children's Antipyretic Medicine Market Size by Country in 2025
Figure 52. South America Children's Antipyretic Medicine Sales Market Share by Country (2021-2032)
Figure 53. South America Children's Antipyretic Medicine Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Children's Antipyretic Medicine Market Size by Country in 2025
Figure 58. Middle East and Africa Children's Antipyretic Medicine Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Children's Antipyretic Medicine Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Children's Antipyretic Medicine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Children's Antipyretic Medicine Sales Market Share by Type (2021-2032)
Figure 66. Global Children's Antipyretic Medicine Revenue Market Share by Type (2021-2032)
Figure 67. Global Children's Antipyretic Medicine Price (US$/Unit) by Type (2021-2032)
Figure 68. Global Children's Antipyretic Medicine Sales Market Share by Application (2021-2032)
Figure 69. Global Children's Antipyretic Medicine Revenue Market Share by Application (2021-2032)
Figure 70. Global Children's Antipyretic Medicine Price (US$/Unit) by Application (2021-2032)
Figure 71. Children's Antipyretic Medicine Value Chain
Figure 72. Children's Antipyretic Medicine Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Children's Antipyretic Medicine Industry Opportunities and Challenges
Scope & coverage.
Types
- Ibuprofen
- Acetaminophen
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Zhejiang Kangle
- Xinhua Pharmaceutical
- Hebei Jiheng
- Changshu Huagang
- Anhui Fubore
- Anhui BBCA Likang
- Temad
- Strides Shasun
- SKPL
- Novacyl
- Mallinckrodt
- IOLCP
- Granules India
- Granules Biocause
- Farmson
- Atabay
- Anqiu Lu'an
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Children's Antipyretic Medicine Market Size (2021-2032)
- 2.2.2 Global Children's Antipyretic Medicine Sales (2021-2032)
- 2.2.3 Global Children's Antipyretic Medicine Market Average Price (2021-2032)
- 2.3 Children's Antipyretic Medicine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ibuprofen
- 2.3.3 Acetaminophen
- 2.3.4 Other
- 2.4 Children's Antipyretic Medicine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Children's Antipyretic Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Children's Antipyretic Medicine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Children's Antipyretic Medicine Revenue of Manufacturers (2021-2026)
- 3.4 Global Children's Antipyretic Medicine Average Price by Manufacturers (2021-2026)
- 3.5 Global Children's Antipyretic Medicine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Children's Antipyretic Medicine, Product Type & Application
- 3.8 Global Manufacturers of Children's Antipyretic Medicine, Established Date
- 3.9 Global Children's Antipyretic Medicine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Kangle
- 4.1.1 Zhejiang Kangle Company Information
- 4.1.2 Zhejiang Kangle Business Overview
- 4.1.3 Zhejiang Kangle Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Kangle Children's Antipyretic Medicine Product Portfolio
- 4.1.5 Zhejiang Kangle Recent Developments
- 4.2 Xinhua Pharmaceutical
- 4.2.1 Xinhua Pharmaceutical Company Information
- 4.2.2 Xinhua Pharmaceutical Business Overview
- 4.2.3 Xinhua Pharmaceutical Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Xinhua Pharmaceutical Children's Antipyretic Medicine Product Portfolio
- 4.2.5 Xinhua Pharmaceutical Recent Developments
- 4.3 Hebei Jiheng
- 4.3.1 Hebei Jiheng Company Information
- 4.3.2 Hebei Jiheng Business Overview
- 4.3.3 Hebei Jiheng Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hebei Jiheng Children's Antipyretic Medicine Product Portfolio
- 4.3.5 Hebei Jiheng Recent Developments
- 4.4 Changshu Huagang
- 4.4.1 Changshu Huagang Company Information
- 4.4.2 Changshu Huagang Business Overview
- 4.4.3 Changshu Huagang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Changshu Huagang Children's Antipyretic Medicine Product Portfolio
- 4.4.5 Changshu Huagang Recent Developments
- 4.5 Anhui Fubore
- 4.5.1 Anhui Fubore Company Information
- 4.5.2 Anhui Fubore Business Overview
- 4.5.3 Anhui Fubore Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Anhui Fubore Children's Antipyretic Medicine Product Portfolio
- 4.5.5 Anhui Fubore Recent Developments
- 4.6 Anhui BBCA Likang
- 4.6.1 Anhui BBCA Likang Company Information
- 4.6.2 Anhui BBCA Likang Business Overview
- 4.6.3 Anhui BBCA Likang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Anhui BBCA Likang Children's Antipyretic Medicine Product Portfolio
- 4.6.5 Anhui BBCA Likang Recent Developments
- 4.7 Temad
- 4.7.1 Temad Company Information
- 4.7.2 Temad Business Overview
- 4.7.3 Temad Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Temad Children's Antipyretic Medicine Product Portfolio
- 4.7.5 Temad Recent Developments
- 4.8 Strides Shasun
- 4.8.1 Strides Shasun Company Information
- 4.8.2 Strides Shasun Business Overview
- 4.8.3 Strides Shasun Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Strides Shasun Children's Antipyretic Medicine Product Portfolio
- 4.8.5 Strides Shasun Recent Developments
- 4.9 SKPL
- 4.9.1 SKPL Company Information
- 4.9.2 SKPL Business Overview
- 4.9.3 SKPL Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SKPL Children's Antipyretic Medicine Product Portfolio
- 4.9.5 SKPL Recent Developments
- 4.10 Novacyl
- 4.10.1 Novacyl Company Information
- 4.10.2 Novacyl Business Overview
- 4.10.3 Novacyl Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novacyl Children's Antipyretic Medicine Product Portfolio
- 4.10.5 Novacyl Recent Developments
- 4.11 Mallinckrodt
- 4.11.1 Mallinckrodt Company Information
- 4.11.2 Mallinckrodt Business Overview
- 4.11.3 Mallinckrodt Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Mallinckrodt Children's Antipyretic Medicine Product Portfolio
- 4.11.5 Mallinckrodt Recent Developments
- 4.12 IOLCP
- 4.12.1 IOLCP Company Information
- 4.12.2 IOLCP Business Overview
- 4.12.3 IOLCP Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 IOLCP Children's Antipyretic Medicine Product Portfolio
- 4.12.5 IOLCP Recent Developments
- 4.13 Granules India
- 4.13.1 Granules India Company Information
- 4.13.2 Granules India Business Overview
- 4.13.3 Granules India Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Granules India Children's Antipyretic Medicine Product Portfolio
- 4.13.5 Granules India Recent Developments
- 4.14 Granules Biocause
- 4.14.1 Granules Biocause Company Information
- 4.14.2 Granules Biocause Business Overview
- 4.14.3 Granules Biocause Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Granules Biocause Children's Antipyretic Medicine Product Portfolio
- 4.14.5 Granules Biocause Recent Developments
- 4.15 Farmson
- 4.15.1 Farmson Company Information
- 4.15.2 Farmson Business Overview
- 4.15.3 Farmson Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Farmson Children's Antipyretic Medicine Product Portfolio
- 4.15.5 Farmson Recent Developments
- 4.16 Atabay
- 4.16.1 Atabay Company Information
- 4.16.2 Atabay Business Overview
- 4.16.3 Atabay Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Atabay Children's Antipyretic Medicine Product Portfolio
- 4.16.5 Atabay Recent Developments
- 4.17 Anqiu Lu'an
- 4.17.1 Anqiu Lu'an Company Information
- 4.17.2 Anqiu Lu'an Business Overview
- 4.17.3 Anqiu Lu'an Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Anqiu Lu'an Children's Antipyretic Medicine Product Portfolio
- 4.17.5 Anqiu Lu'an Recent Developments
5 Global Children's Antipyretic Medicine Market Scenario by Region
- 5.1 Global Children's Antipyretic Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Children's Antipyretic Medicine Sales by Region: 2021-2032
- 5.2.1 Global Children's Antipyretic Medicine Sales by Region: 2021-2026
- 5.2.2 Global Children's Antipyretic Medicine Sales by Region: 2027-2032
- 5.3 Global Children's Antipyretic Medicine Revenue by Region: 2021-2032
- 5.3.1 Global Children's Antipyretic Medicine Revenue by Region: 2021-2026
- 5.3.2 Global Children's Antipyretic Medicine Revenue by Region: 2027-2032
- 5.4 North America Children's Antipyretic Medicine Market Facts & Figures by Country
- 5.4.1 North America Children's Antipyretic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Children's Antipyretic Medicine Sales by Country (2021-2032)
- 5.4.3 North America Children's Antipyretic Medicine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Children's Antipyretic Medicine Market Facts & Figures by Country
- 5.5.1 Europe Children's Antipyretic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Children's Antipyretic Medicine Sales by Country (2021-2032)
- 5.5.3 Europe Children's Antipyretic Medicine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Children's Antipyretic Medicine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Children's Antipyretic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Children's Antipyretic Medicine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Children's Antipyretic Medicine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Children's Antipyretic Medicine Market Facts & Figures by Country
- 5.7.1 South America Children's Antipyretic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Children's Antipyretic Medicine Sales by Country (2021-2032)
- 5.7.3 South America Children's Antipyretic Medicine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Children's Antipyretic Medicine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Children's Antipyretic Medicine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Children's Antipyretic Medicine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Children's Antipyretic Medicine Sales by Type (2021-2032)
- 6.1.1 Global Children's Antipyretic Medicine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Children's Antipyretic Medicine Sales Market Share by Type (2021-2032)
- 6.2 Global Children's Antipyretic Medicine Revenue by Type (2021-2032)
- 6.2.1 Global Children's Antipyretic Medicine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Children's Antipyretic Medicine Revenue Market Share by Type (2021-2032)
- 6.3 Global Children's Antipyretic Medicine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Children's Antipyretic Medicine Sales by Application (2021-2032)
- 7.1.1 Global Children's Antipyretic Medicine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Children's Antipyretic Medicine Sales Market Share by Application (2021-2032)
- 7.2 Global Children's Antipyretic Medicine Revenue by Application (2021-2032)
- 7.2.1 Global Children's Antipyretic Medicine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Children's Antipyretic Medicine Revenue Market Share by Application (2021-2032)
- 7.3 Global Children's Antipyretic Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Children's Antipyretic Medicine Value Chain Analysis
- 8.1.1 Children's Antipyretic Medicine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Children's Antipyretic Medicine Production Mode & Process
- 8.2 Children's Antipyretic Medicine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Children's Antipyretic Medicine Distributors
- 8.2.3 Children's Antipyretic Medicine Customers
9 Global Children's Antipyretic Medicine Analyzing Market Dynamics
- 9.1 Children's Antipyretic Medicine Industry Trends
- 9.2 Children's Antipyretic Medicine Industry Drivers
- 9.3 Children's Antipyretic Medicine Industry Opportunities and Challenges
- 9.4 Children's Antipyretic Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst